Enovis (ENOV) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Enovis Corp  (NYSE: ENOV)
 

Enovis Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Enovis Corp inventory turnover ratio, the Enovis Corp's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.49 in the second quarter 2026, yet the ratio remained below the average, as ENOV's market remain challenging.Average inventory processing period, for the Enovis in Jul 03 2026 quarter, has decreased to 245 days, compare to 247 days, in the Apr 03 2026 quarter.

Within Healthcare sector 258 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1714, from total ranking in the first quarter 2026 at 1857.

ENOV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Enovis Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ENOV Inventory Turnover Ratio (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Oct 03 2025)
III. Quarter		 (Jul 04 2025)
II. Quarter
Y / Y Inventory Growth -4.23 % 2.84 % 6.81 % 0.67 % 2.14 %
Y / Y Cost of Sales Growth -2.39 % -1.33 % -10.24 % 0.46 % -2.97 %
Inventory Turnover Ratio (TTM) 1.49 1.48 1.5 1.56 1.56
ENOV's Total Ranking # 1714 # 1857 # 1757 # 1760 # 1749
Average inventory processing period 245 247 244 234 233
Seq. Inventory Growth -0.15 % 3.11 % -4.79 % -2.3 % 7.22 %
Seq. Cost of Sales Growth 0.24 % -2.19 % 4.11 % -4.37 % 1.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 118
Healthcare Sector # 259
Overall Market # 1714

Inventory Turnover Ratio Statistics
High Average Low
6.47 4.02 1.49
(Mar 28 2014)   (Apr 03 2026)



ENOV Company Profile >> Back to ENOV Efficiency Comparisons >> Compare ENOV Inventory Turnover Ratio to its Competitors

Financial Statements
Enovis's Inventories $ 602 Millions Visit ENOV's Balance sheet
Enovis's Cost of Revenues TTM $ 894 Millions Visit ENOV's Income Statement
What are ENOV's Sales? Visit ENOV's Sales by Segment

Other Inventory Turnover Ratios
Enovis's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ENOV's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ENOV's Competitors
Inventory Turnover Ratio for ENOV's Suppliers
Inventory Turnover Ratio for ENOV's Customers

You may also want to know
ENOV's Sales Growth Rates ENOV's Pe Price to earnings ratio ENOV's Receivables Turnover Ratio ENOV's Stock Quote
ENOV's Net Income Growth Rates ENOV's Ps Price to Sales ratio ENOV's Sales per Employee ENOV's Asset Turnover Ratio
ENOV's Net Margin ENOV's Pb Price to Book ratio ENOV's Financial Strength Ratios ENOV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 03 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 03 2026 Inventories at quarter ending Jul 03 2026
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Resmed Inc   2.97 $ 2,770.562  Millions$ 933  Millions

Date modified: 2026-09-07T22:17:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.